A cancer vaccine has shown promise in eliciting a strong immune response in patients with pancreatic and colorectal cancer. The vaccine, which may be a universal or off-the-shelf treatment, has reportedly produced durable responses in some cases. It is unclear if the vaccine is specifically designed for these cancer types or if it has broader applications, with some research suggesting it could potentially be used to attack cancer cells more generally.